JPS5519270A - Tumor controlling substance and medicine containing it - Google Patents

Tumor controlling substance and medicine containing it

Info

Publication number
JPS5519270A
JPS5519270A JP9209779A JP9209779A JPS5519270A JP S5519270 A JPS5519270 A JP S5519270A JP 9209779 A JP9209779 A JP 9209779A JP 9209779 A JP9209779 A JP 9209779A JP S5519270 A JPS5519270 A JP S5519270A
Authority
JP
Japan
Prior art keywords
tumor
sarcosine
medicine containing
controlling substance
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9209779A
Other languages
English (en)
Inventor
Osubuaruto Hansu
Yusefu Maamuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of JPS5519270A publication Critical patent/JPS5519270A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Surgical Instruments (AREA)
  • Toys (AREA)
  • Window Of Vehicle (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP9209779A 1978-07-20 1979-07-19 Tumor controlling substance and medicine containing it Pending JPS5519270A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782832009 DE2832009A1 (de) 1978-07-20 1978-07-20 Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Publications (1)

Publication Number Publication Date
JPS5519270A true JPS5519270A (en) 1980-02-09

Family

ID=6044955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9209779A Pending JPS5519270A (en) 1978-07-20 1979-07-19 Tumor controlling substance and medicine containing it

Country Status (13)

Country Link
US (1) US4766149A (ja)
EP (1) EP0007597B1 (ja)
JP (1) JPS5519270A (ja)
AT (1) ATE11220T1 (ja)
AU (1) AU529657B2 (ja)
CA (1) CA1151065A (ja)
DD (1) DD144864A5 (ja)
DE (1) DE2832009A1 (ja)
DK (1) DK305479A (ja)
FI (1) FI792218A (ja)
MC (1) MC1271A1 (ja)
NO (1) NO792398L (ja)
ZA (1) ZA793603B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
US4994492A (en) * 1989-01-09 1991-02-19 Foodscience Corporation Treatment of melanoma using N,N-dimethylglycine
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
DE4026184A1 (de) * 1990-08-18 1992-02-20 Henkel Kgaa Verfahren zur verminderung des restgehaltes an freiem alkylierungsmittel in waessrigen loesungen kationischer tenside
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1847274A1 (en) * 2006-04-21 2007-10-24 CIPROSA LLC - Corporate Creations Network, Inc. Association of phenylbutyrate, ATRA and cytidine and its use in anti-tumour therapy
EP3415910A1 (en) 2017-06-16 2018-12-19 Prevention Medicals s.r.o. A method of quantitative determination of sarcosine in a biological sample using anti-arcosine antibodies and peroxidase-active gold nanoparticles or quantum dots

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE553424C (de) * 1928-04-18 1932-06-27 Karl Luedecke Dr Verfahren zur Herstellung von Praeparaten, die das Wachstum von Geweben durch Verminderung der Teilungsfaehigkeit oder Aufloesung der wuchernden Zellen einschraenken
BE647556A (ja) * 1964-05-06 1964-08-31
FR2085637A1 (fr) * 1970-04-15 1971-12-31 Etude Des Catalyseurs Soc D Composition pharmaceutique utilisable notamment contre l'asthenie
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEM ABSTR. *
CHEM.ABSTR *

Also Published As

Publication number Publication date
ATE11220T1 (de) 1985-02-15
DK305479A (da) 1980-01-21
DD144864A5 (de) 1980-11-12
DE2832009C2 (ja) 1988-07-28
EP0007597B1 (de) 1985-01-16
AU4907679A (en) 1980-01-24
MC1271A1 (fr) 1980-05-23
AU529657B2 (en) 1983-06-16
DE2832009A1 (de) 1980-01-31
EP0007597A1 (de) 1980-02-06
ZA793603B (en) 1980-07-30
CA1151065A (en) 1983-08-02
NO792398L (no) 1980-01-22
FI792218A (fi) 1980-01-21
US4766149A (en) 1988-08-23

Similar Documents

Publication Publication Date Title
ES478047A1 (es) Procedimiento para la obtencion de acidos 4-piridon-3-car- boxilicos.
DE2961074D1 (en) Phosphoryl aminoacid derivatives and composition for treating hypertension containing the same
ES8608974A1 (es) Procedimiento para preparar una composicion de polvo de tan-talo
HU178663B (en) Fungicide compositions containing cyanopirrole derivatives as active agents,and process for producing the active agents
JPS5519270A (en) Tumor controlling substance and medicine containing it
HUT41214A (en) Fungicide compositions containing heterocyclic compounds as active ingredients and process for preparing the active compounds
ES8103051A1 (es) Un metodo de preparar nuevos derivados de pirazolina
NZ334961A (en) Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
DE3164944D1 (en) 3,4,5-trihydroxypiperidine derivatives, process for their preparation, their use as medicines and in animal feeding
YU59974A (en) Process for preparing new compositions suitable as soilimproving and fertilizing agents in agriculture
DE3270446D1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
ES8201578A1 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
AU523909B2 (en) 1,2,3-triazole carboxylic acid amides and their use as biocid biocides
ES478795A1 (es) Procedimiento para fabricar dilignoles y compuestos simila- res al dilignol.
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
ES8105271A1 (es) Procedimiento para la obtencion de anilidas de acido ciclo- alcan (alquen) carboxilico,de efecto fungicida
ZA791768B (en) Dichlorobenzodioxole derivatives,process for their preparation and their use as synergistic agents in insecticidal and acaricidal compositions
HUT36992A (en) Herbicide compositions containing tetrazole derivatives as active substances and process for preparing the active substances
JPS5571689A (en) Liquid foliar fertilizer composition containing waterrsoluble ureaaformaldehyde product
DE3379502D1 (en) (+)-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
JPS5556087A (en) Granular compound fertilizer composition
PT80490A (de) Verfahren zur herstellung von synergistischen herbiziden verbindungen die eine mischungans o-<3-phenyl-6-chlor-pyridazinyl-(4)>-s-(n-octyl)-thiocarbonat,2-chlor-4-athylamino-6-isopropylamino-1,3,5-triazin und einen chloracetamid